Cancer immunotherapies that harness the body's immune system to combat tumors have
received extensive attention and become mainstream strategies for treating cancer. Despite …

Recent studies have demonstrated great therapeutic potential of educating and unleashing
our own immune system for cancer treatment. However, there are still major challenges in …

Immunotherapy is moving to the frontier of cancer treatment. Drug delivery systems (DDSs)
have greatly advanced the development of cancer immunotherapeutic regimen and …

Based on the previously described roles of doxorubicin in immunogenic cell death, both
doxorubicin and liposomal doxorubicin (Doxil) were evaluated for their ability to boost the …

Targeted delivery of nanomedicines to M2 tumor-associated macrophages (TAMs) has been
proposed to reduce tumor promotion and enhance the efficacy of anticancer therapy …

Research in novel drug delivery systems is being explored competitively in order to attain
maximum therapeutic effect while minimizing the adverse effects. Despite several …

The immunologic and therapeutic effects of intratumoral (IT) delivery of a novel virus-like
particle as a lymphoma immunotherapy were evaluated in preclinical studies with human …

Oral vaccines have become a recent focus because of their potential significance in disease
prevention and therapy. In the development of oral vaccine-based therapeutics, synthetic …

The immune system has the function of immune surveillance to resist the occurrence and
development of tumors, and is essential for inhibition of tumor metastasis. Nevertheless …

Ataxia–telangiectasia (AT) is a type of primary immunodeficiency characterized by an
autosomal recessive mode of inheritance and usually presents with progressive cerebellar …